OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A discrete choice experiment on oral and injection treatment preferences among moderate‐to‐severe psoriasis patients in Japan
Mayumi Komine, Hyunchung Kim, Jingbo Yi, et al.
The Journal of Dermatology (2023) Vol. 50, Iss. 6, pp. 766-777
Open Access | Times Cited: 14
Mayumi Komine, Hyunchung Kim, Jingbo Yi, et al.
The Journal of Dermatology (2023) Vol. 50, Iss. 6, pp. 766-777
Open Access | Times Cited: 14
Showing 14 citing articles:
An Oral Interleukin-23–Receptor Antagonist Peptide for Plaque Psoriasis
Robert Bissonnette, Andreas Pinter, Laura K. Ferris, et al.
New England Journal of Medicine (2024) Vol. 390, Iss. 6, pp. 510-521
Closed Access | Times Cited: 31
Robert Bissonnette, Andreas Pinter, Laura K. Ferris, et al.
New England Journal of Medicine (2024) Vol. 390, Iss. 6, pp. 510-521
Closed Access | Times Cited: 31
Safety, Tolerability, and Pharmacokinetics of an Oral Small Molecule Inhibitor of IL‐17A (LY3509754 ): A Phase I Randomized Placebo‐Controlled Study
Amita Datta‐Mannan, Arie Regev, David E. Coutant, et al.
Clinical Pharmacology & Therapeutics (2024) Vol. 115, Iss. 5, pp. 1152-1161
Open Access | Times Cited: 13
Amita Datta‐Mannan, Arie Regev, David E. Coutant, et al.
Clinical Pharmacology & Therapeutics (2024) Vol. 115, Iss. 5, pp. 1152-1161
Open Access | Times Cited: 13
Exploring the Therapeutic Landscape: A Narrative Review on Topical and Oral Phosphodiesterase-4 Inhibitors in Dermatology
Elena Carmona‐Rocha, Lluís Rusiñol, L. Puig
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 91-91
Open Access | Times Cited: 1
Elena Carmona‐Rocha, Lluís Rusiñol, L. Puig
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 91-91
Open Access | Times Cited: 1
Deucravacitinib in plaque psoriasis: Safety and efficacy through 3 years in Japanese patients in the phase 3 POETYK PSO ‐1, PSO ‐4, and LTE trials
Akimichi Morita, Shinichi Imafuku, Yayoi Tada, et al.
The Journal of Dermatology (2025)
Open Access | Times Cited: 1
Akimichi Morita, Shinichi Imafuku, Yayoi Tada, et al.
The Journal of Dermatology (2025)
Open Access | Times Cited: 1
Orismilast in moderate-to-severe psoriasis: Efficacy and safety from a 16-week, randomized, double-blinded, placebo-controlled, dose-finding, and phase 2b trial (IASOS)
Richard B. Warren, Lars E. French, Andrew Blauvelt, et al.
Journal of the American Academy of Dermatology (2023) Vol. 90, Iss. 3, pp. 494-503
Open Access | Times Cited: 12
Richard B. Warren, Lars E. French, Andrew Blauvelt, et al.
Journal of the American Academy of Dermatology (2023) Vol. 90, Iss. 3, pp. 494-503
Open Access | Times Cited: 12
An overview of small-molecule agents for the treatment of psoriasis
Zhiheng Jin, Gang Li, Dengqin He, et al.
Bioorganic & Medicinal Chemistry (2025) Vol. 119, pp. 118067-118067
Closed Access
Zhiheng Jin, Gang Li, Dengqin He, et al.
Bioorganic & Medicinal Chemistry (2025) Vol. 119, pp. 118067-118067
Closed Access
Patient Experiences and Preferences Regarding Medication Cost Discussions Among Heart Failure Patients in Singapore: A Qualitative Survey
Qianyu Shen, Dennis Chin Wee Chua, Po Fun Chan, et al.
Patient Preference and Adherence (2025) Vol. Volume 19, pp. 407-418
Open Access
Qianyu Shen, Dennis Chin Wee Chua, Po Fun Chan, et al.
Patient Preference and Adherence (2025) Vol. Volume 19, pp. 407-418
Open Access
On the horizon; considerations on convenience of oral biologic agents in psoriasis
Seán O’Malley, Clióna Feighery
International Journal of Pharmacy Practice (2025)
Closed Access
Seán O’Malley, Clióna Feighery
International Journal of Pharmacy Practice (2025)
Closed Access
Active Switch From a Single Dose of Bimekizumab to Risankizumab in Psoriasis: A Pilot Study
Kaori Nakajima, Tomomitsu Miyagaki, Tatsuro Okano, et al.
The Journal of Dermatology (2025)
Closed Access
Kaori Nakajima, Tomomitsu Miyagaki, Tatsuro Okano, et al.
The Journal of Dermatology (2025)
Closed Access
Patient-centred Preferences for Biologic Therapies in Moderate to Severe Psoriasis in Vietnam: A Discrete Choice Experiment
Chuyen Thi Hong Nguyen, Nguyễn Thị Xuân, Trung The Van
Acta Dermato Venereologica (2025) Vol. 105, pp. adv42840-adv42840
Open Access
Chuyen Thi Hong Nguyen, Nguyễn Thị Xuân, Trung The Van
Acta Dermato Venereologica (2025) Vol. 105, pp. adv42840-adv42840
Open Access
GRAPPA Debate: Targeted Small Molecules Versus Biologics as First-Line Systemic Therapy After Conventional Therapy for Moderate-to-Severe Psoriasis
Wilson Liao, April W. Armstrong, Kristina Callis Duffin
The Journal of Rheumatology (2024) Vol. 51, Iss. Suppl 2, pp. 89-92
Closed Access | Times Cited: 2
Wilson Liao, April W. Armstrong, Kristina Callis Duffin
The Journal of Rheumatology (2024) Vol. 51, Iss. Suppl 2, pp. 89-92
Closed Access | Times Cited: 2
Psoriasis: a focus on upcoming oral formulations
Lluís Rusiñol, Elena Carmona‐Rocha, L. Puig
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 7, pp. 583-600
Closed Access | Times Cited: 4
Lluís Rusiñol, Elena Carmona‐Rocha, L. Puig
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 7, pp. 583-600
Closed Access | Times Cited: 4
Treatment patterns of systemic drug use in Japanese patients with plaque psoriasis: A retrospective chart review
Yayoi Tada, Mayumi Komine, Yukari Okubo, et al.
The Journal of Dermatology (2023) Vol. 51, Iss. 2, pp. 210-222
Open Access | Times Cited: 4
Yayoi Tada, Mayumi Komine, Yukari Okubo, et al.
The Journal of Dermatology (2023) Vol. 51, Iss. 2, pp. 210-222
Open Access | Times Cited: 4
Oral Psoriasis Therapies
JaBreia F. James, T. Otto, Julia Gao, et al.
Dermatologic Clinics (2024) Vol. 42, Iss. 3, pp. 357-363
Closed Access | Times Cited: 1
JaBreia F. James, T. Otto, Julia Gao, et al.
Dermatologic Clinics (2024) Vol. 42, Iss. 3, pp. 357-363
Closed Access | Times Cited: 1
